Orange County Business Journal reported that Epinal Inc., a corporate entity based in the municipality of Irvine, has been actively advancing a specialized technological initiative. The enterprise known as Epinal Inc. has dedicated a substantial timeframe consisting of six years of development to this overarching project.
The primary technical achievement stemming from this extensive period of six years of development is the creation of a semiconductor-based biosensor. According to the factual details of the project, this semiconductor-based biosensor is specifically engineered to accomplish a distinct analytical task: the device detects narcotics from human breath. The integration of advanced semiconductor-based biosensor architecture with the ability to identify narcotics from human breath forms the core competency of Epinal Inc. as an Irvine-based organization.
Throughout the span of six years of development, researchers and specialists associated with Epinal Inc. have focused heavily on refining the semiconductor-based biosensor. The technical considerations inherent in creating a device that detects narcotics from human breath have required the entirety of the six years of development that the Irvine-based firm has undertaken thus far.
Looking toward the future operational timeline of the enterprise, leadership at Epinal Inc. has established a clear scheduling objective. The company, which operates out of Irvine, is currently targeting the year 2028 to begin production of the semiconductor-based biosensor. This projected timeline provides a concrete horizon for when the technology capable of detecting narcotics from human breath may transition from the research phase managed over six years of development into actual manufacturing by Epinal Inc.
The profound human reasons driving the creation of the semiconductor-based biosensor were underscored by commentary reflecting on global struggles with health and substance challenges. Addressing the severe personal losses experienced globally, Mark Wong told Orange County Business Journal, "People around the world lose loved ones every day to narcotics and various diseases, myself included."
Building upon this sentiment regarding the human cost of narcotics and diseases, Mark Wong further explained the preventative philosophy embraced by Epinal Inc. Highlighting the critical role of timely medical and technological oversight, Mark Wong told Orange County Business Journal, "We feel that with proactive screening and monitoring, countless lives can be saved with early detection and treatment."
As Epinal Inc. moves forward from its base in Irvine toward its overarching manufacturing objectives, the combination of six years of development, the semiconductor-based biosensor designed to detect narcotics from human breath, and the goal to reach the year 2028 to begin production remains the definitive roadmap for the enterprise.
